🔎 Trials Near Me

Akèy › Dyabèt tip 1 › New York › New York City

Etid klinik pou Dyabèt tip 1 nan New York City, NY

15 etid pou Dyabèt tip 1 ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

App-Based Certified Diabetes Education Therapy (AB-CDE)

Ap rekrite
  • Mount Sinai School of Medicine, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07282639

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Ap rekriteFaz 3
  • Endocrine Associates of West Village- Site Number : 8400064, New York
  • Columbia University Irving Medical Center- Site Number : 8400009, New York
Laj 1 a 25 · Tout sèks · Mizajou Sep 14, 2026 · NCT07088068

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Ap rekriteFaz 1/2
  • Hassenfield Children's Hospital, New York
  • NYU Langone Diabetes & Endocrine Associates, New York
Laj 12 a 35 · Tout sèks · Mizajou Sep 11, 2026 · NCT06783309

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

Ap rekriteFaz 2
  • Columbia University, New York
Laj 4 a 34 · Tout sèks · Mizajou Sep 9, 2026 · NCT07216391

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

Ap rekriteFaz 2
  • Columbia University, New York
Laj 8 a 45 · Tout sèks · Mizajou Sep 8, 2026 · NCT07142252

HLA Demographics Study in Adults With Type 1 Diabetes

Ap rekriteEtid obsèvasyon
  • Icahn School of Medicine at Mount Sinai, New York
Laj 18 a 55 · Tout sèks · Mizajou Aug 28, 2026 · NCT06860516

Long-Term Outcomes of Teplizumab in Routine Clinical Care

Ap rekriteEtid obsèvasyon
  • Investigational Site Number: 8400001, New York
Tout laj · Tout sèks · Mizajou Aug 25, 2026 · NCT07360080

APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life

Ap rekrite
  • Weill Cornell Medicine, New York
Laj 18 a 75 · Tout sèks · Mizajou Aug 19, 2026 · NCT07773779

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

Ap rekriteFaz 1
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University, New York
Laj 18 a 55 · Tout sèks · Mizajou Aug 10, 2026 · NCT06919354

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

Ap rekriteEtid obsèvasyon
  • Mount Sinai, New York
Laj 18 ak plis · Tout sèks · Mizajou Jun 30, 2026 · NCT07676565

Kidney Precision Medicine Project

Ap rekriteEtid obsèvasyon
  • Mount Sinai, New York
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT04334707

Cholesterol Lowering and Residual Risk in Diabetes, Type 1

Ap rekriteFaz 4
  • New York VA Hospital, New York
  • NYC Health + Hospitals/Bellevue, New York
  • NYU Langone Health, New York
  • ak 1 plis
Laj 18 a 89 · Tout sèks · Mizajou Dec 29, 2025 · NCT05641753

TrialNet Pathway to Prevention of T1D

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Columbia University, New York
Laj 2 a 45 · Tout sèks · Mizajou Jul 1, 2025 · NCT00097292

NYSCF Scientific Discovery Biobank

Ap rekriteEtid obsèvasyon
  • New York Stem Cell Foundation Research Institute, New York
30 Days · Tout sèks · Mizajou Mar 3, 2025 · NCT06203106

PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mt Sinai, New York
0 Days – 99 Years · Tout sèks · Mizajou Nov 21, 2023 · NCT06141434

Etid Dyabèt tip 1 nan lòt vil

Lòt etid nan New York City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.